Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.

By M. Davies, R. Bergenstal, B. Bode, R. Kushner, A. Lewin, T. V. Skjøth, A. H. Andreasen, C. Jensen, Ralph DeFronzo. Journal of the American Medical Association (JAMA), 2015

1,033 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery

View Paper: https://www.semanticscholar.org/paper/2b13d7d82098f7f35e25b3f87d654444a331f770

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. J. Meier
2. M. Nauck

In Molecular Biology

1. M. Nauck
2. J. Meier

In Surgery

1. J. Meier
2. M. Nauck

Citations in the corpus

• GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art (2020, background): “Some data suggest that while HbA1c reduction plateaus at relatively lower doses, higher doses may still be more effective for weight loss [69,70].”